Citadel Advisors’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,049,614
Closed -$19.8M 14556
2022
Q1
$19.8M Buy
2,049,614
+174,559
+9% +$1.69M ﹤0.01% 1998
2021
Q4
$18.3M Buy
+1,875,055
New +$18.2M ﹤0.01% 2136

Other funds holding AFTR

Citadel Advisors's AFTR Position: Q2 2022 in Review

Citadel Advisors sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q2 2022, closing a stake of 2,049,614 shares — an estimated $19.8M sold.

Citadel Advisors first reported a position in AFTR in Q4 2021 and held it in 2 quarters. The position peaked at $19.8M in Q1 2022. 47 funds tracked by Wall St. Rank hold AFTR as of Q2 2022.

  • Citadel Advisors reported no remaining AfterNext HealthTech Acquisition Corp position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 2,049,614 AfterNext HealthTech Acquisition Corp shares in Q2 2022, an estimated $19.8M.
  • Citadel Advisors first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 2 quarters.
  • Citadel Advisors's AfterNext HealthTech Acquisition Corp position peaked at $19.8M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.